AsOf

Recorded or changed on this day 2026-11-08

251–300 of 46,459 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,756,333,032 shares
Abbott Laboratories shares outstanding: 1,756,333,032 shares, claim clm_66C9CF7C9C4F · ended · superseded by clm_2216B46B8180 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 684,000,000 United States dollar
Abbott Laboratories quarterly research and development: 684,000,000 United States dollar, claim clm_67490CE86700 · ended · superseded by clm_B51405589AC1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 782,000,000 United States dollar
Abbott Laboratories quarterly research and development: 782,000,000 United States dollar, claim clm_6768B441C8E0 · ended · superseded by clm_602C8D08E319 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 8,809,339,000 United States dollar
Abbott Laboratories cash and equivalents: 8,809,339,000 United States dollar, claim clm_68D91286EA36 · ended · superseded by clm_8831A07FE77A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 31,817,000,000 United States dollar
Abbott Laboratories total equity: 31,817,000,000 United States dollar, claim clm_6AC71DAEDCE7 · ended · superseded by clm_1226C199906C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 7,369,000,000 United States dollar
Abbott Laboratories cash and equivalents: 7,369,000,000 United States dollar, claim clm_6AD344300D4A · ended · superseded by clm_CAD5272C9D86 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 575,000,000 United States dollar
Abbott Laboratories quarterly research and development: 575,000,000 United States dollar, claim clm_6B0B3077A414 · ended · superseded by clm_41B5CF7870D0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 9,978,000,000 United States dollar
Abbott Laboratories quarterly revenue: 9,978,000,000 United States dollar, claim clm_6B2DDDB45AF4 · ended · superseded by clm_3885AF18E04D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 25,453,691,000 United States dollar
Abbott Laboratories total equity: 25,453,691,000 United States dollar, claim clm_6B7C46E76D25 · ended · superseded by clm_40993F6FAAEB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 67,610,000,000 United States dollar
Abbott Laboratories total assets: 67,610,000,000 United States dollar, claim clm_6BF87C6DF992 · ended · superseded by clm_B5CB1DFE9334 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 8,054,000,000 United States dollar
Abbott Laboratories cash and equivalents: 8,054,000,000 United States dollar, claim clm_6CBAE76E6610 · ended · superseded by clm_4D07CC32DA31 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 6,718,368,000 United States dollar
Abbott Laboratories quarterly revenue: 6,718,368,000 United States dollar, claim clm_6D1B34C8DAA9 · ended · superseded by clm_3BEDCDE314E8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 62,004,241,000 United States dollar
Abbott Laboratories total assets: 62,004,241,000 United States dollar, claim clm_6D8509B0B286 · ended · superseded by clm_E8CD9FA5F500 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 2,376,000,000 United States dollar
Abbott Laboratories quarterly operating income: 2,376,000,000 United States dollar, claim clm_6DD49D4EE601 · ended · superseded by clm_886971CE1D04 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 26,378,853,000 United States dollar
Abbott Laboratories total equity: 26,378,853,000 United States dollar, claim clm_6DF1F94B8785 · ended · superseded by clm_B0304BE94341 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 2,500,000,000 United States dollar
Abbott Laboratories cash and equivalents: 2,500,000,000 United States dollar, claim clm_6E48EACB3253 · ended · superseded by clm_30F5C427EA78 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 51,110,000,000 United States dollar
Abbott Laboratories total equity: 51,110,000,000 United States dollar, claim clm_6E93433192ED · ended · superseded by clm_1774BA675DC1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 8,076,000,000 United States dollar
Abbott Laboratories quarterly revenue: 8,076,000,000 United States dollar, claim clm_6EA4DA762D97 · ended · superseded by clm_0C0541A5EB25 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 10,223,000,000 United States dollar
Abbott Laboratories quarterly revenue: 10,223,000,000 United States dollar, claim clm_6EAE7D00A853 · ended · superseded by clm_D28ACE81B29C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 43,653,000,000 United States dollar
Abbott Laboratories revenue: 43,653,000,000 United States dollar, claim clm_6FD3450A3DD5 · ended · superseded by clm_8BADD4D79F8F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 4,204,304,000 United States dollar
Abbott Laboratories cash and equivalents: 4,204,304,000 United States dollar, claim clm_7367F0AB540E · ended · superseded by clm_359398B95B4A · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · agreement · Exact Sciences Corporation
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 73,017,000,000 United States dollar
Abbott Laboratories total assets: 73,017,000,000 United States dollar, claim clm_73D720E01EFC · ended · superseded by clm_BCEDE84B5D8A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,746,333,892 shares
Abbott Laboratories shares outstanding: 1,746,333,892 shares, claim clm_749951A1C0C9 · ended · superseded by clm_4A012C69AC0E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,693,000,000 United States dollar
Abbott Laboratories quarterly operating income: 1,693,000,000 United States dollar, claim clm_75BE91C87765 · ended · superseded by clm_D4D65248DFB6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 42,686,613,000 United States dollar
Abbott Laboratories total assets: 42,686,613,000 United States dollar, claim clm_765D69CF45D0 · ended · superseded by clm_01D207199632 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · net income · 6,524,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,490,441,465 shares
Abbott Laboratories shares outstanding: 1,490,441,465 shares, claim clm_771836F657A2 · ended · superseded by clm_96EE5B28A5A8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 810,000,000 United States dollar
Abbott Laboratories quarterly operating income: 810,000,000 United States dollar, claim clm_77913BAAC587 · ended · superseded by clm_455364238A9E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 283,000,000 United States dollar
Abbott Laboratories quarterly net income: 283,000,000 United States dollar, claim clm_77D0019EBF2D · ended · superseded by clm_4061F715D3A7 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · registrant name · ABBOTT LABORATORIES
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 7,767,000,000 United States dollar
Abbott Laboratories quarterly revenue: 7,767,000,000 United States dollar, claim clm_79374FAAB118 · ended · superseded by clm_DE1BAF682D4F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 7,497,660,000 United States dollar
Abbott Laboratories quarterly revenue: 7,497,660,000 United States dollar, claim clm_79675DAFEFFB · ended · superseded by clm_6D1B34C8DAA9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,198,000,000 United States dollar
Abbott Laboratories quarterly operating income: 1,198,000,000 United States dollar, claim clm_79BB0F5ED4DC · ended · superseded by clm_E25EFE866047 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · shares outstanding · 1,731,941,601 shares
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · revenue · 44,328,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 6,532,000,000 United States dollar
Abbott Laboratories cash and equivalents: 6,532,000,000 United States dollar, claim clm_7C1DF4950D60 · ended · superseded by clm_F462DB1216CF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 30,925,000,000 United States dollar
Abbott Laboratories total equity: 30,925,000,000 United States dollar, claim clm_7D62673F73F6 · ended · superseded by clm_B94747095EFB · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · fiscal year end · 12-31
Abbott Laboratories fiscal year end: 12-31, claim clm_7EA8A2BEA2BF · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 72,090,000,000 United States dollar
Abbott Laboratories total assets: 72,090,000,000 United States dollar, claim clm_7F56B9F9D8D3 · ended · superseded by clm_603966F4450A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 672,000,000 United States dollar
Abbott Laboratories quarterly net income: 672,000,000 United States dollar, claim clm_7FCB849C8A66 · ended · superseded by clm_CEF1F2D39061 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,767,397,615 shares
Abbott Laboratories shares outstanding: 1,767,397,615 shares, claim clm_8048076BF037 · ended · superseded by clm_18993939AE37 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 5,302,000,000 United States dollar
Abbott Laboratories quarterly revenue: 5,302,000,000 United States dollar, claim clm_8064646C7C6E · ended · superseded by clm_15BAEA02B893 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 38,851,259,000 United States dollar
Abbott Laboratories revenue: 38,851,259,000 United States dollar, claim clm_80F33B0D967B · ended · superseded by clm_B4C1932FF6FA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 23,602,000,000 United States dollar
Abbott Laboratories total equity: 23,602,000,000 United States dollar, claim clm_820EF0E3F09E · ended · superseded by clm_FE809BBE39B1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 20,538,000,000 United States dollar
Abbott Laboratories total equity: 20,538,000,000 United States dollar, claim clm_8210275EABD7 · ended · superseded by clm_B7DCB616777F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,771,529,358 shares
Abbott Laboratories shares outstanding: 1,771,529,358 shares, claim clm_826A1DC08AE8 · ended · superseded by clm_1F524FFD747D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,556,576,533 shares
Abbott Laboratories shares outstanding: 1,556,576,533 shares, claim clm_8274522F4DD8 · ended · superseded by clm_E7CEC88C5131 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 5,104,000,000 United States dollar
Abbott Laboratories quarterly revenue: 5,104,000,000 United States dollar, claim clm_82A6A707FD7C · ended · superseded by clm_217D209218A4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · net income · 3,687,000,000 United States dollar
Abbott Laboratories net income: 3,687,000,000 United States dollar, claim clm_82D437604E1A · ended · superseded by clm_492C7215F04B · 1 source (1 primary) · conf 0.95

What the statuses mean